lifestyle.sourcefed.com

Author: ABBOTT LABORATORIES

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

March 12, 2026
Abbott and Real Madrid launch nationwide effort to build the next ‘Abbott Dream Team’

March 11, 2026
Abbott declares 409th consecutive quarterly dividend

February 20, 2026
Late-breaking data presentations showcase the safety and efficacy of Abbott’s ablation catheters to treat people with atrial fibrillation

February 12, 2026
Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

January 23, 2026
Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

January 20, 2026
Abbott’s FreeStyle Libre 3 Plus Now Covered Across Canada

January 7, 2026
Abbott hosts conference call for fourth-quarter earnings

January 5, 2026
Abbott’s new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions

January 5, 2026
Abbott’s Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation

December 22, 2025